A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia

Condition:   Leukemia, Myeloid, Acute Interventions:   Drug: CC-90009;   Drug: Venetoclax;   Drug: Azacitidine;   Drug: Gilteritinib Sponsors:   Celgene;   AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials